Octreotide - NDC Database

92 records found

Page:1

0078-0340 Nov 01, 1988
Sandostatin Lar Depot Kit by Novartis Pharmaceuticals Corporation

0078-0341 Nov 01, 1988
Sandostatin Lar Depot Kit by Novartis Pharmaceuticals Corporation

0078-0342 Nov 01, 1988
Sandostatin Lar Depot Kit by Novartis Pharmaceuticals Corporation

0078-0646 Feb 01, 2015
Sandostatin Lar Depot Kit by Novartis Pharmaceuticals Corporation

0078-0647 Feb 01, 2015
Sandostatin Lar Depot Kit by Novartis Pharmaceuticals Corporation

0078-0648 Feb 01, 2015
Sandostatin Lar Depot Kit by Novartis Pharmaceuticals Corporation

0078-0811 Jul 22, 2016
Sandostatin Lar Depot Kit by Novartis Pharmaceuticals Corporation

0078-0818 Jul 22, 2016
Sandostatin Lar Depot Kit by Novartis Pharmaceuticals Corporation

0078-0825 Jul 22, 2016
Sandostatin Lar Depot Kit by Novartis Pharmaceuticals Corporation

0078-9342 Nov 01, 1988
Sandostatin Lar Depot Demonstration Kit Kit by Novartis Pharmaceuticals Corporation

0480-9257 Mar 20, 2025
Octreotide AcetateOctreotide Acetate Intramuscular Kit by Teva Pharmaceuticals, Inc.

0480-9259 Oct 01, 2024
Octreotide AcetateOctreotide Acetate Intramuscular Kit by Teva Pharmaceuticals, Inc.

0480-9262 Oct 01, 2024
Octreotide AcetateOctreotide Acetate Intramuscular Kit by Teva Pharmaceuticals, Inc.

0641-6174 Apr 04, 2005
Octreotide Acetate 50 ug/ml Intravenous; Subcutaneous Injection, Solution by West-ward Pharmaceuticals Corp.

0641-6175 Apr 04, 2005
Octreotide Acetate 100 ug/ml Intravenous; Subcutaneous Injection, Solution by West-ward Pharmaceuticals Corp.

0641-6176 Apr 04, 2005
Octreotide Acetate 500 ug/ml Intravenous; Subcutaneous Injection, Solution by West-ward Pharmaceuticals Corp.

0641-6177 Apr 08, 2005
Octreotide Acetate 200 ug/ml Intravenous; Subcutaneous Injection, Solution by West-ward Pharmaceuticals Corp.

0641-6178 Apr 08, 2005
Octreotide Acetate 1000 ug/ml Intravenous; Subcutaneous Injection, Solution by West-ward Pharmaceuticals Corp.

0703-3301 Nov 14, 2005
Octreotide Acetate 50 ug/ml Intravenous; Subcutaneous Injection by Teva Parenteral Medicines, Inc

0703-3311 Nov 14, 2005
Octreotide Acetate 100 ug/ml Intravenous; Subcutaneous Injection by Teva Parenteral Medicines, Inc

Page:1

Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.